entertainment -WSS

entertainment

author：hotspot 2025-10-01 22:58:18 - browse：682

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： The thinking behind the controversial eating disorder chatbot Tessa

WSS

Multiple sclerosis has subtypes with different best treatments: study

Overprescribed: High cost isn't America's only drug problem

Covid silver lining: Unprecedented look at human immune system

Bird flu reported in person exposed to presumably infected cattle

Hundreds died while taking an arthritis drug, but nobody alerted patients

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

entertainment

entertainment

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Biden administration plans revamp of organ transplant system

Medical records are filled with copy

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Medical leaders decry Supreme Court decision on affirmative action

Medicare Advantage 2025 payments will dip, Biden administration says

Hepatitis C has a cure — but many Americans still lack access to it

Gut bacteria may contribute to kidney autoimmunity, study finds

Psychedelics group wrestles with new pharma identity

FDA approves first new drug developed for postpartum depression

leisure time

Pancreatic cancer is often deadly, but new discoveries are raising hope

Drug companies' payments and gifts affect physicians' prescribing

Bispecific antibodies are next new thing in cancer immunotherapy

Living organ donors deserve priority status for transplants

Bird flu reported in person exposed to presumably infected cattle

Multiple sclerosis has subtypes with different best treatments: study

focus

hotspot

explore

leisure time